 |
9 Diseases |  |
0 Trials |
|
0 Trials |  |
92 News |  |
| «12 |
- gp96-Ig vaccine / Sylvester Comprehensive Cancer Center, viagenpumatucel-L (HS-110) / NightHawk Biosci
Trial completion, Metastases: Vaccine Therapy in Treating Patients With Stage III, Stage IV, or Relapsed Non-Small Cell Lung Cancer Treated With First-Line Chemotherapy (clinicaltrials.gov) - Oct 15, 2012
P1, N=19, Completed, Sponsor: University of Miami Sylvester Comprehensive Cancer Center
Active, not recruiting --> Completed
- viagenpumatucel-L (HS-110) / NightHawk Biosci
New P2a trial, Combination therapy, Metastases: Immune Response and Safety of HS110 Vaccine in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer (clinicaltrials.gov) - Jan 3, 2012
P2a, N=0, Withdrawn, Sponsor: Heat Biologics